Tower Research Capital LLC (Trc) Graphite Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.24 - $2.66 $188 - $223	84 Added 1.89%	4,521 $11,000
Q3 2023 Nov 14, 2023	BUY	$2.18 - $2.77 $2,711 - $3,445	1,244 Added 38.96%	4,437 $11,000
Q2 2023 Aug 14, 2023	SELL	$2.47 - $3.38 $4,008 - $5,485	-1,623 Reduced 33.7%	3,193 $8,000
Q1 2023 May 09, 2023	BUY	$1.85 - $3.21 $4,995 - $8,667	2,700 Added 127.6%	4,816 $11,000
Q4 2022 Feb 10, 2023	SELL	$2.82 - $3.59 $12,309 - $15,670	-4,365 Reduced 67.35%	2,116 $7,000
Q3 2022 Nov 10, 2022	BUY	$2.82 - $4.24 $16,257 - $24,443	5,765 Added 805.17%	6,481 $21,000
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $4,416 - $10,794	-2,064 Reduced 74.24%	716 $2,000
Q1 2022 May 12, 2022	SELL	$5.1 - $13.06 $16,223 - $41,543	-3,181 Reduced 53.36%	2,780 $14,000
Q4 2021 Feb 14, 2022	BUY	$8.41 - $16.71 $44,404 - $88,228	5,280 Added 775.33%	5,961 $74,000
Q3 2021 Nov 15, 2021	BUY	$15.81 - $28.39 $10,766 - $19,333	681 New	681 $11,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.